Get the Stockscreener App
85.68
1.09%
-0.94
After Hours:
85.98
0.30
+0.35%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Colgate Palmolive Co stock is traded at $85.68, with a volume of 4.37M.
It is down -1.09% in the last 24 hours and down -2.12% over the past month.
Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.
See More
Previous Close:
$86.62
Open:
$87.19
24h Volume:
4.37M
Relative Volume:
0.99
Market Cap:
$70.00B
Revenue:
$20.10B
Net Income/Loss:
$2.89B
P/E Ratio:
24.34
EPS:
3.52
Net Cash Flow:
$3.55B
1W Performance:
-5.73%
1M Performance:
-2.12%
6M Performance:
-16.54%
1Y Performance:
+2.32%
1-Day Range:
$85.35
$87.20
1-Week Range:
$85.33
$87.39
52-Week Range:
$82.68
$109.30
Colgate Palmolive Co Stock (CL) Company Profile
Name
Colgate Palmolive Co
Sector
Industry
Phone
(212) 310-2000
Address
300 PARK AVE, NEW YORK, NY
Compare CL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
85.68 | 70.00B | 20.10B | 2.89B | 3.55B | 3.52 |
|
PG
Procter Gamble Co
|
168.88 | 396.00B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
58.07 | 144.70B | 64.93B | 7.15B | 0 | 2.832 |
|
KMB
Kimberly Clark Corp
|
128.69 | 42.70B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
19.80 | 37.96B | 15.46B | 1.06B | 1.40B | 0.55 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-28-24 | Downgrade | Stifel | Buy → Hold |
| Sep-24-24 | Initiated | Piper Sandler | Overweight |
| Sep-16-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-09-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-24 | Initiated | TD Cowen | Buy |
| Jun-24-24 | Initiated | Exane BNP Paribas | Outperform |
| Mar-01-24 | Resumed | Goldman | Buy |
| Jan-29-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Oct-16-23 | Upgrade | Stifel | Hold → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Buy |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-22-22 | Initiated | Wolfe Research | Peer Perform |
| Oct-13-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-01-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-08-22 | Initiated | Raymond James | Mkt Perform |
| Feb-02-22 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Jan-31-22 | Reiterated | Citigroup | Neutral |
| Jan-31-22 | Reiterated | Credit Suisse | Outperform |
| Jan-31-22 | Reiterated | Deutsche Bank | Buy |
| Jan-31-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-31-22 | Reiterated | Wells Fargo | Underweight |
| Dec-16-21 | Initiated | Redburn | Neutral |
| Oct-05-21 | Resumed | BofA Securities | Neutral |
| Sep-20-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-24-21 | Initiated | UBS | Buy |
| Jun-09-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-01-21 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jan-28-21 | Downgrade | Stifel | Buy → Hold |
| Jan-26-21 | Upgrade | Berenberg | Sell → Hold |
| Jan-20-21 | Initiated | Bernstein | Underperform |
| Jan-04-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-08-20 | Initiated | Wells Fargo | Underweight |
| Jul-22-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-27-20 | Upgrade | Stifel | Hold → Buy |
| Mar-27-20 | Upgrade | SunTrust | Hold → Buy |
| Mar-23-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-03-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Feb-03-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-19-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-16-19 | Initiated | Berenberg | Sell |
| Apr-29-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-07-19 | Initiated | Credit Suisse | Underperform |
| Feb-11-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Jan-11-19 | Initiated | Evercore ISI | Outperform |
| Jan-09-19 | Upgrade | Goldman | Neutral → Buy |
| Oct-29-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-26-18 | Downgrade | SunTrust | Buy → Hold |
| Jul-30-18 | Downgrade | Macquarie | Outperform → Neutral |
| May-25-18 | Upgrade | Argus | Hold → Buy |
| Apr-30-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
View All
Colgate Palmolive Co Stock (CL) Latest News
Colgate-Palmolive (NYSE:CL) Shares Sold by Boston Trust Walden Corp - MarketBeat
Colgate-Palmolive (NYSE:CL) Given New $104.00 Price Target at Morgan Stanley - MarketBeat
Cullinan Associates Inc. Cuts Holdings in Colgate-Palmolive (NYSE:CL) - MarketBeat
Stock Yards Bank & Trust Co. Cuts Holdings in Colgate-Palmolive (NYSE:CL) - MarketBeat
Colgate-Palmolive (NYSE:CL) Given New $93.00 Price Target at Stifel Nicolaus - MarketBeat
Is Colgate-Palmolive Company (CL) the Best Beauty Stock to Buy According to Hedge Funds? - Insider Monkey
EnsembleIQ’s Product of the Year Canada Announces 2025 Award Winners - GlobeNewswire Inc.
abrdn plc Cuts Stock Holdings in Colgate-Palmolive (NYSE:CL) - MarketBeat
Colgate-Palmolive (NYSE:CL) Given New $97.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Is Colgate-Palmolive Company (CL) the Best Dividend Stock to Buy and Hold? - Insider Monkey
Independence Bank of Kentucky Has $708,000 Stock Holdings in Colgate-Palmolive (NYSE:CL) - MarketBeat
Do Wall Street Analysts Like Colgate-Palmolive Stock? - Barchart
Colgate-Palmolive (NYSE:CL) Given New $100.00 Price Target at UBS Group - MarketBeat
Concord Wealth Partners Grows Stock Position in Colgate-Palmolive (NYSE:CL) - MarketBeat
Mediolanum International Funds Ltd Sells 201,770 Shares of Colgate-Palmolive (NYSE:CL) - MarketBeat
Colgate-Palmolive (NYSE:CL) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Colgate-Palmolive's Diana Haussling Named CEO of Hello Products - MSN
Colgate-Palmolive's SWOT analysis: stock faces headwinds amid strong brand portfolio - Investing.com
Dentsply Sirona, Colgate, Henry Schein among 500 U.S. companies recognized by Newsweek for sustainability - Oral Health
Welch Group LLC Raises Position in Colgate-Palmolive (NYSE:CL) - MarketBeat
Colgate-Palmolive Sees Weaker Annual Sales On Slower Demand - Checkout
Colgate-Palmolive (NYSE:CL) Stock Position Reduced by Cibc World Market Inc. - MarketBeat
Colgate-Palmolive (NYSE:CL) Shares Gap DownHere's Why - MarketBeat
TD Cowen holds Colgate-Palmolive stock with $100 target - Investing.com India
Buy Colgate-Palmolive (India), target price Rs 3,215: Centrum Broking - MSN
Stifel cuts Colgate-Palmolive stock price target to $93 from $95 - Investing.com Canada
Colgate-Palmolive’s Strategic Initiatives and Market Position Reinforce Buy Rating Despite Challenges - TipRanks
TD Cowen Reiterates Buy Rating on Colgate-Palmolive Company (CL) - StreetInsider.com
Colgate-Palmolive Analysts Slash Their Forecasts After Q4 Results - Benzinga
Colgate-Palmolive (NYSE:CL) Receives "Outperform" Rating from Raymond James - MarketBeat
Raymond James cuts Colgate-Palmolive target to $105 - MSN
Stifel cuts Colgate-Palmolive stock price target to $93 from $95 By Investing.com - Investing.com South Africa
Barclays maintains Colgate stock at Equalweight, $83 target By Investing.com - Investing.com South Africa
Colgate-Palmolive's SWOT analysis: stock resilient amid global challenges - Investing.com
Barclays maintains Colgate stock at Equalweight, $83 target - Investing.com
Barclays Reiterates Equalweight Rating on Colgate-Palmolive Company (CL) - StreetInsider.com
Colgate Announces 4th Quarter and Full Year 2024 Results -February 03, 2025 at 05:31 am EST - Marketscreener.com
Musk's X sues Lego, Nestlé, Colgate, Shell over alleged ad boycott - CampaignLive
Jim Cramer on Colgate-Palmolive Company (CL): ‘Colgate Forecasts Flat, I Was Surprised’ - Insider Monkey
Musk’s X Expands Lawsuit Against Nestle, Colgate-Palmolive & Others Over Ad Boycott - BW Marketing World
Sumitomo Life Insurance Co. Increases Stock Holdings in Colgate-Palmolive (NYSE:CL) - MarketBeat
Strategic Blueprint LLC Has $1.16 Million Stock Holdings in Colgate-Palmolive (NYSE:CL) - MarketBeat
BDF Gestion Cuts Stock Position in Colgate-Palmolive (NYSE:CL) - MarketBeat
Corporate Earnings Reveal Mixed Results For Q4 2024 - Evrim Ağacı
Colgate Women's Games 2025 - messenger-inquirer
Colgate-Palmolive’s stock slips on weaker-than-expected guidance despite Q4 profit beat - MSN
Colgate-Palmolive sees weaker annual sales on demand slowdown - MSN
Is Colgate-Palmolive Company (CL) the Best Defensive Stock to Buy Right Now? - Insider Monkey
Colgate Palmolive Co Stock (CL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.43%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):